No black box warning on record for Olmesartan Medoxomil-Hydrochlorothiazide
As of the latest FDA labeling reviewed, Olmesartan Medoxomil-Hydrochlorothiazide (OLMESARTAN MEDOXOMIL-HYDROCHLOROTHIAZIDE) does not carry a black box warning. Standard warnings and precautions still apply — see the full Olmesartan Medoxomil-Hydrochlorothiazide medicine page for the complete safety profile.